Company intelligence / Profile preview

Celligenics

Singapore, Singapore
Ownership
Private
Employees
~25
Development stage
Other
01

Overview

Celligenics is a Singapore-based biotechnology company specializing in regenerative medicine through its proprietary cell-free secretome technology. The company focuses on harnessing the therapeutic potential of stem cell-derived secretomes, which contain a rich mix of growth factors and exosomes, to treat various conditions without the complexities of live cell transplantation. Their primary therapeutic areas include chronic wound healing, particularly diabetic foot ulcers, as well as aesthetics and musculoskeletal disorders. By utilizing a standardized and scalable manufacturing process, Celligenics aims to provide off-the-shelf regenerative solutions that are safer and more cost-effective than traditional stem cell therapies. The company's approach bridges the gap between advanced stem cell research and practical clinical applications in dermatology and orthopedics.

Therapeutic areas
RheumatologyEndocrinologyDermatology
Modalities
Exosome-based therapyCell-free therapyBiologic
Industry
Biotech
02

Drug pipeline

1 asset

CGN1

Unknown

Beyond the preview

Go deeper on Celligenics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Celligenics.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call